Skip to content

HORIZONFP7H2020

Centre de Recherches Medicales de Lambaréné

Country
GAGabon
Defence projects
0
Projects, all programmes
16
As coordinator
0
EU contribution (CORDIS)
EUR 7,507,906
Active
2010 to 2025

Projects

16 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ACROBAT NewbornsAppraising the Critical Role of prognostic Biomarkers in the Assessment and Triage of sick African newborns: Advancing a point-of-care device based on sTREM-1 towards CE marking and implementationHORIZON2025ParticipantEUR 343,750
AFRICAI-RIA Pan-African Research Infrastructure for Collaborative Biomedical Imaging and Artificial Intelligence in Respiratory CareHORIZON2025ParticipantNot stated
ASAAP-plusClinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African childrenHORIZON2024ParticipantEUR 136,875
CATCRCentral Africa Training Platform for Clinical Research on infectious diseasesHORIZON2024ParticipantEUR 788,407
WORMVACS2.0Innovations for vaccines against helminth infectionsHORIZON2023ParticipantEUR 665,000
eWHORMEnabling the WHO-Roadmap 2030HORIZON2023ParticipantEUR 1,417,600
PANGenSPan-Africa network for genomic surveillance of poverty related diseases and emerging pathogensHORIZON2023ParticipantEUR 177,237
VICI-DISEASEPROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINEHORIZON2023Associated partnerEUR 0
INTEGRATEThe Integrate study : An adaptive platform trial for the development of a new intervention to combat Lassa fever in AfricaHORIZON2023ParticipantEUR 111,500
EChiLiBRiSTDevelopment and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survivalHORIZON2022ParticipantEUR 1,142,687
ORCHESTRAConnecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRAH20202020ParticipantEUR 360,000
VSV-EBOPLUSSYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068H20202016ParticipantEUR 752,150
VSV-EBOVACVaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842H20202015ParticipantEUR 118,875
HOOKVACDeveloping and Testing a novel, low-cost, effective HOOKworm VACcine to Control Human Hookworm Infection in endemic countriesFP72013ParticipantEUR 994,800
THESCHISTOVACThe targeted development of a new generation Vaccine for SchistosomiasisFP72010ParticipantEUR 106,988
IDEADissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research InitiativeFP72010ParticipantEUR 392,037

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.